Literature DB >> 25368029

Mineralocorticoid receptor antagonists for the treatment of hypertension and the metabolic syndrome.

Bertram Pitt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25368029     DOI： 10.1161/HYPERTENSIONAHA.114.04117

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  3 in total

1.  Attenuation of hypertension and renal damage in renovascular hypertensive rats by iron restriction.

Authors:  Makiko Oboshi; Yoshiro Naito; Hisashi Sawada; Toshihiro Iwasaku; Yoshitaka Okuhara; Akiyo Eguchi; Shinichi Hirotani; Toshiaki Mano; Takeshi Tsujino; Tohru Masuyama
Journal:  Hypertens Res       Date:  2016-07-21       Impact factor: 3.872

2.  Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4-Year Follow-Up.

Authors:  Alessia Buglioni; Valentina Cannone; S Jeson Sangaralingham; Denise M Heublein; Christopher G Scott; Kent R Bailey; Richard J Rodeheffer; Riccardo Sarzani; John C Burnett
Journal:  J Am Heart Assoc       Date:  2015-12-23       Impact factor: 5.501

Review 3.  Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences.

Authors:  So-Hyeon Hong; Kyung Mook Choi
Journal:  Int J Mol Sci       Date:  2020-01-13       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.